medmix AG

    Jurisdiction
    Switzerland
    LEI
    529900PL4KLKJVMULW74
    ISIN
    CH1129677105 (MEDX.SW)
    Sectors
    1. Industrials
    2. Industrial - Machinery

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. Read full profile

    Fundamentals

    Net revenue
    €1.04B
    Gross margin
    32.7%
    EBIT
    €32.75M
    EBIT margin
    3.2%
    Net income
    -€7.60M
    Net margin
    -0.7%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €494.93M -52.4% €13.15M -273.1%
    €519.75M +5.0% €24.10M +83.2%
    €551.10M +6.0% €36.80M +52.7%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    CHF 0.50
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications